Biotech
Beyfortus® (nirsevimab) is an available option designed to protect all infants – whether born full-term or pre-term, healthy or with underlying...
November 25, 2025 | News
Nona Biosciences, a global biotechnology company providing integrated solutions for biological drug discovery and development from I to I® (Idea t...
November 20, 2025 | News
Initiative led by researchers in Australia and Japan aims to map cancer and immune interactions to advance precision oncology across the region 10x Genomi...
November 19, 2025 | News
Vaccines remain the cornerstone of infectious disease control, but traditional development pathways are slow and resource‐intensive. Modern chall...
November 10, 2025 | Analysis
4DMT to receive $85 million upfront cash payment and expect to receive at least $50 million of cost sharing from Otsuka over the next three years for dev...
November 04, 2025 | News
4DMT to receive $85 million upfront cash payment and expect to receive at least $50 million of cost sharing from Otsuka over the next three years for dev...
November 04, 2025 | News
Cancer care in Southeast Asia stands at a critical crossroads. While awareness of early detection is high, the translation into meaningful action remains p...
October 01, 2025 | Interaction | By arcilla.fran@biopharmaapac.com
eXmoor Pharma, the integrated cell and gene therapy CDMO with embedded consultancy expertise, and Siam Bioscience, a leading biopharmaceutical company in A...
September 24, 2025 | News
SOPHiA GENETICS an AI technology company transforming precision medicine announced an expansion of its collaboration with AstraZeneca (LSE/STO/Nasdaq:...
September 23, 2025 | News
Evonik, a global specialty chemicals company, and Ethris, a clinical-stage biotechnology company pioneering next-generation RNA therapeutics and vaccines, ...
September 10, 2025 | News
Fairtility, a global leader in transparent AI for reproductive care, announced that its CHLOE platform has achieved U.S. Food and Drug Administration...
September 05, 2025 | News
Approximately 800 children aged 12 months to 12 years in Korea and abroad, aiming for completion by 2027 Rising demand for 2-dose regimen as internation...
September 03, 2025 | News
Highly Complementary Technologies Strengthen Thermo Fisher’s Portfolio in Bioprocessing and Adjacent Markets Thermo Fisher Scientific Inc. , the wor...
September 02, 2025 | News
BioPharma APAC spoke with Jane Li, Senior Director, Pharma CDx and CRO Partnership at Thermo Fisher Scientific, about the development of the Oncomine&trade...
August 25, 2025 | Expert Insight
Most Read
Bio Jobs
News
Editor Picks